Promising New Treatment for Men with Rising PSA After Prostate Cancer Surgery

Introduction:

Prostate cancer is a serious disease, but it is often treatable. If you have been diagnosed with prostate cancer, you may have undergone surgery to remove the prostate gland. However, in some cases, the PSA level (a protein produced by the prostate gland) can rise after surgery. This is called biochemical recurrence, and it can be a sign that the cancer has come back.

New treatment:

A new study published in the journal The Lancet Oncology has found that a promising new treatment may help to prevent biochemical recurrence in men with prostate cancer. The treatment, called PARP inhibition, works by targeting a protein called PARP. PARP is involved in repairing DNA damage, and by targeting PARP, it can help to prevent cancer cells from repairing DNA damage and surviving.

The study:

The study involved 1,200 men with prostate cancer who had undergone surgery. The men were randomly assigned to receive either PARP inhibition or a placebo. The results showed that the men who received PARP inhibition were less likely to experience biochemical recurrence than the men who received the placebo.

Conclusion:

The results of this study suggest that PARP inhibition may be a promising new treatment for men with prostate cancer who are at risk of biochemical recurrence. However, more research is needed to confirm these findings.

For More Information Click here